<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="93e3355d-5d2a-47ab-bbc0-1da5b196448a"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Barbara Jordan</title>
  <effectiveTime value="20260420120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="ef6db12f-61d3-4054-8bed-2b235ec1a8dd"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="3034c5d8-f97a-4deb-9c0d-48f4bd4dcd03" extension="HR-ML030-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-30-6852"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Barbara</given><family>Jordan</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19820221"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260420120000-0500"/>
    <assignedAuthor><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260420120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260420"/><high value="20260420"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="70c7296e-dd55-47c2-9439-d6971fd4e17c"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Five-week review: second vaccine doses, baclofen titration, physical therapy and readiness for the first infusion</originalText></code>
      <effectiveTime><low value="20260420"/><high value="20260420"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Five-week review: second vaccine doses, baclofen titration, physical therapy, and readiness for the first infusion. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Jordan returns five weeks after the consultation. Baclofen 5 mg three times a day made her drowsy for the first week; this has passed, and her mornings are less stiff. Mirabegron has helped: she now gets up once most nights. She had a sore arm for a day after the vaccines and no other reaction. She has had no new symptoms and no infection. The physical therapy evaluation requested at intake has not happened: the clinic&apos;s therapist with experience in multiple sclerosis has a waiting list, and she has not yet been offered a date. Her employer has agreed to the accommodations she asked for. She would like the infusions on days without teaching. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Baclofen</td><td>Drowsy the first week, now settled; stiffness better</td></tr><tr><td>Bladder</td><td>Up once most nights on mirabegron</td></tr><tr><td>Physical therapy</td><td>Not yet seen; waiting list</td></tr><tr><td>Work</td><td>Accommodations agreed</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No fever or infection</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>Urgency better; no burning</td></tr><tr><td>Musculoskeletal</td><td>Positive</td><td>Mild morning stiffness</td></tr><tr><td>Neurological</td><td>Negative</td><td>No new numbness, weakness or visual change</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Cholecalciferol (vitamin D3) 2000 units (50 mcg) oral capsule, one capsule daily</td><td>One capsule daily</td><td>Oral route</td><td>2026-03-02</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Baclofen 5 mg oral tablet, one tablet three times a day, to be increased to 10 mg three times a day once tolerated</td><td>One tablet three times a day</td><td>Oral route</td><td>2026-03-16 to 2026-04-20</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Baclofen 10 mg oral tablet, one tablet three times a day</td><td>One tablet three times a day</td><td>Oral route</td><td>2026-04-20</td><td>active</td><td>S</td></tr><tr ID="medication-4"><td>Mirabegron 25 mg extended-release oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-03-16</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="79a2b894-3c2a-4f7f-8ce1-c74af65ad8bc"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260302"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="804146" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.05 MG Oral Capsule"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b0b937d2-262e-482d-8052-85591906e481"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="25526a6a-467f-4e14-a072-8e494ae69e71"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260316"/><high value="20260420"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="430902" codeSystem="2.16.840.1.113883.6.88" displayName="baclofen 5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="bef41be1-83f2-4215-84b7-7133b3e655ba"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G35.B1" codeSystem="2.16.840.1.113883.6.90" displayName="Active primary progressive multiple sclerosis"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="0d2b579e-c619-4675-862d-be125022a4b3"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R26.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other abnormalities of gait and mobility"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="4ee3ea07-d5d7-427f-b2ce-090a2caed158"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260420"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197391" codeSystem="2.16.840.1.113883.6.88" displayName="baclofen 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3a4d2aef-1f9a-49a3-a916-4d98839c301a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G35.B1" codeSystem="2.16.840.1.113883.6.90" displayName="Active primary progressive multiple sclerosis"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="94e321c1-b447-4edf-bae3-9dbff1c1687d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R26.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other abnormalities of gait and mobility"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="70451e5a-d582-461b-94b8-4e6bdab1cd63"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260316"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1300791" codeSystem="2.16.840.1.113883.6.88" displayName="24 HR mirabegron 25 MG Extended Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4fed380e-0139-4c0a-a251-bb691731a294"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N31.9" codeSystem="2.16.840.1.113883.6.90" displayName="Neuromuscular dysfunction of bladder, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="472ff1b9-91aa-43a4-bc69-10f97eb176e5"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="107984ae-1c45-44c6-b2e9-3d8dd5f2b336"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>2026-04-20</td><td>Body height</td><td>173</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>2026-04-20</td><td>Body weight</td><td>83.8</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>2026-04-20</td><td>Body mass index (BMI) [Ratio]</td><td>28</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>2026-04-20</td><td>Systolic blood pressure</td><td>120</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>2026-04-20</td><td>Diastolic blood pressure</td><td>76</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>2026-04-20</td><td>Heart rate</td><td>72</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>2026-04-20</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>2026-04-20</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>2026-04-20</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>99</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="c6b78c99-7be0-4f2e-9b95-9d5a56241366"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260420"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c19264e4-470d-49cc-a519-a0cac3fe9f85"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="173" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="d0f7099e-ea11-4773-9e09-3d3c30d3219a"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="83.8" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ebbb9ce2-7e00-443c-9497-aff47a13fa4b"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="28" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="348914b7-0ce6-4e03-81f5-a8abfc87822c"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="120" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8a474081-7f8c-47fe-acdf-c8fb652787eb"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="76" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="39ca136e-d45b-4800-998f-7af594e6cd6a"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="72" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="541aead8-afe9-4bd1-86c5-bc60dcba4e7f"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="e3b9e67e-db9f-4f52-b24e-1aa8c4b750e9"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1db824da-dc79-4889-9e83-8ca3b2cac982"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="20260420"/><value xsi:type="PQ" value="99" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-04-20; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; blood pressure 120/76, pulse 72; temperature 36.6 °C</td></tr><tr><td>Neurological</td><td>Gait unchanged with a cane; modified Ashworth 1+ in both legs; hip flexor strength 4 out of 5, unchanged with baclofen</td></tr><tr><td>Skin</td><td>No rash; vaccine sites healed</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Multiple sclerosis diagnosed elsewhere, by her account, with records of the original evaluation not available: slowly worsening walking over the past few years, leg stiffness, fatigue, urinary urgency and heat sensitivity; uses a cane; course to be classified after MRI of the brain and spine</td><td>resolved</td><td>confirmed</td>
    <td>G35.D</td><td>S — Synthetic presenting picture at intake, superseded by the classified diagnosis at the consultation; the cane and a diagnosis around the time she left Congress are from public accounts.</td>
  </tr>
  <tr ID="problem-2">
    <td>Active primary progressive multiple sclerosis: gradual worsening of walking over more than a year without relapses, with brain lesions in periventricular, juxtacortical and infratentorial regions, three spinal cord lesions, and one gadolinium-enhancing lesion; fulfils the 2017 McDonald criteria for primary progressive disease; EDSS 6.0; synthetic modern detail linked to her publicly reported multiple sclerosis</td><td>active</td><td>confirmed</td>
    <td>G35.B1</td><td>S — Synthetic course, MRI findings and disability score; the disease itself and her use of a cane are from public accounts.</td>
  </tr>
  <tr ID="problem-3">
    <td>Spastic gait from multiple sclerosis, walking with a cane, with two near-falls and no falls in the past year; at risk of falls</td><td>active</td><td>confirmed</td>
    <td>R26.89</td><td>S — Synthetic modern coding anchored to her documented cane.</td>
  </tr>
  <tr ID="problem-4">
    <td>Neurogenic bladder from multiple sclerosis: urgency and getting up twice at night, with a low post-void residual</td><td>active</td><td>confirmed</td>
    <td>N31.9</td><td>S — Synthetic; common in multiple sclerosis. No public source describes her bladder.</td>
  </tr>
  <tr ID="problem-5">
    <td>Vitamin D deficiency</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic laboratory finding at intake.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c83ad7e0-9d41-49c9-9054-41f61197b5b6"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260302"/><high value="20260316"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c5b5e313-9ad3-4e71-b55e-bc7b8497111b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260302"/><high value="20260316"/></effectiveTime>
          <value xsi:type="CD" code="G35.D" codeSystem="2.16.840.1.113883.6.90" displayName="Multiple sclerosis, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="0980b52d-525d-46c5-a05f-607c55d242cf"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260316"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="6fdfd136-423a-47a5-a7c3-3b320b5b4967"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260316"/></effectiveTime>
          <value xsi:type="CD" code="G35.B1" codeSystem="2.16.840.1.113883.6.90" displayName="Active primary progressive multiple sclerosis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="fc87a847-1f48-43f9-bf62-74e32b855425"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="33e36a6a-9531-4feb-b5c2-d00ec20ee6f2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260302"/></effectiveTime>
          <value xsi:type="CD" code="R26.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other abnormalities of gait and mobility"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="3d7ccefa-5bd5-449c-baa9-2187465a9b10"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="8f0c88eb-e8aa-4c92-b903-68b4a095337c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260302"/></effectiveTime>
          <value xsi:type="CD" code="N31.9" codeSystem="2.16.840.1.113883.6.90" displayName="Neuromuscular dysfunction of bladder, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="73cbfcc7-090e-44d0-9f92-a21c773440e2"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="0ea591b5-b7d1-4739-8df9-130269fb0e42"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260302"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Active primary progressive multiple sclerosis (G35.B1)</content>. Stable, with no infection; ready for ocrelizumab after today&apos;s vaccines. [S]<list><item>Recombinant zoster dose 2 and hepatitis B dose 2 today.</item><item>First ocrelizumab half-dose in two weeks and the second two weeks later, on days without teaching, with premedication and at least one hour of observation.</item><item>Infusion center to confirm no active infection before each dose.</item></list></item><item><content styleCode="Bold">Spastic gait and fall risk (R26.89)</content>. Baclofen tolerated with less stiffness and no added weakness. The physical therapy evaluation is overdue. [S]<list><item>Increase baclofen to 10 mg three times a day.</item><item>Clinic to ask the physical therapy service today for the first available date, with a second provider if none is offered within three weeks.</item><item>Daily stretching and her home exercises meanwhile.</item></list></item><item><content styleCode="Bold">Neurogenic bladder (N31.9)</content>. Better on mirabegron; blood pressure unchanged. [S]<list><item>Continue mirabegron 25 mg daily.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>New or worsening symptoms (relapse, pseudo-relapse with heat or infection)</td><td>Every visit</td><td>Completed today</td><td>No new symptoms</td></tr><tr><td>Examination</td><td>Disability: EDSS and timed 25-foot walk</td><td>Every visit, and at least every 6 months</td><td>Up to date</td><td>EDSS 6.0 five weeks ago; gait unchanged today</td></tr><tr><td>Imaging</td><td>Brain MRI</td><td>At diagnosis with gadolinium; re-baseline 3 to 6 months after starting therapy; then yearly without routine gadolinium</td><td>Up to date</td><td>Diagnostic MRI five weeks ago; re-baseline due three to six months after the first dose</td></tr><tr><td>Medication safety</td><td>Vaccines before therapy (PCV20, recombinant zoster x2, Tdap, hepatitis B x2)</td><td>Inactivated at least 2 weeks and live at least 4 weeks before the first dose</td><td>Completed today</td><td>Zoster dose 2 and hepatitis B dose 2 today; series complete; first infusion two weeks from today</td></tr><tr><td>Medication safety</td><td>Infusion reactions and infections</td><td>Each infusion, and every visit</td><td>Completed today</td><td>No infection today; premedication and observation planned</td></tr><tr><td>Examination</td><td>Spasticity (modified Ashworth) and baclofen tolerance</td><td>Every visit</td><td>Completed today</td><td>Modified Ashworth 1+; baclofen increased to 10 mg three times a day</td></tr><tr><td>Examination</td><td>Bladder: urgency, nocturia, urinary infection, and blood pressure on mirabegron</td><td>Every visit</td><td>Completed today</td><td>Nocturia once; blood pressure 120/76 on mirabegron</td></tr><tr><td>Referral</td><td>Falls, walking aids and physical therapy</td><td>Every visit</td><td>Deferred</td><td>Missed: the physical therapy evaluation requested at intake has not happened because of a waiting list. No harm so far: no falls and her gait is unchanged. Corrective action: the clinic asked the service today for the first available date, with a second provider if none is offered within three weeks; daily stretching and home exercises meanwhile</td></tr><tr><td>Self-management</td><td>Workplace accommodation</td><td>At intake and with any change</td><td>Completed today</td><td>Accommodations agreed by her employer</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Diagnosis confirmed and classified, vaccines completed at least two weeks before therapy, and a disease-modifying therapy started within ten weeks. In progress; target 2026-06-29 [S]</item><item>No falls through eight months. In progress; target 2026-10-26 [S]</item><item>25-hydroxyvitamin D at least 30 ng/mL within four months. In progress; target 2026-06-29 [S]</item><item>Up no more than once a night to pass urine within three months. In progress; target 2026-06-29 [S]</item><item>Keep her full teaching and speaking schedule with the accommodations she chooses. In progress; target 2026-10-26 [S]</item><item>No new or enlarging T2 lesions on the re-baseline MRI. In progress; target 2026-10-26 [S]</item></list><paragraph>Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2; Recombinant zoster vaccine, dose 2 of 2 [S]</paragraph><paragraph>Guideline basis: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis (Rae-Grant A, et al.; PMID 29686116) (2018); 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis (Wattjes MP, et al.; PMID 34139157) (2021); Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis (Farez MF, et al.; PMID 31462584) (2019); OCREVUS (ocrelizumab) injection, prescribing information (2026); Multiple sclerosis in adults: management (NG220) (2022); Accommodation and Compliance: Multiple Sclerosis (2026); Introduction to the Americans with Disabilities Act (2026); Adult Immunization Schedule by Age (2026); CMID: Clinical Monitoring Intelligence Database, osteoporosis and depression monographs (2026)</paragraph><paragraph>Follow-up: Ocrelizumab infusions in two and four weeks at the infusion center. Review six weeks after the second infusion with a blood count, CD19 count, vitamin D and the PHQ-9. Next scheduled visit 2026-06-29: four-month review, six weeks after the first ocrelizumab doses: infusion tolerance, infections, blood counts, vitamin D, heat and mood. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
